Inventiva (IVA) Total Current Liabilities (2018 - 2025)
Inventiva (IVA) posted quarterly Total Current Liabilities of $90.1 million for Q4 2025, down 30.18% year-over-year from $129.0 million in Q4 2024, and down 99.86% quarter-over-quarter from $66.2 billion in Q2 2025.
Analysis
Inventiva (IVA) Total Current Liabilities (2018 - 2025) Analysis & Trends
Inventiva's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $90.1 million for Q4 2025.
- In Q4 2025, Total Current Liabilities fell 30.18% year-over-year to $90.1 million; the TTM figure through Dec 2025 stood at $90.1 million (down 30.18% YoY), while the FY2025 annual figure was $90.1 million, down 30.18% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $90.1 million, down from $66.2 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $66.2 billion in Q2 2025, with the low at $20460.9 in Q2 2024.
- The 5-year median for Total Current Liabilities is $36.2 million (2022), against an average of $7.7 billion.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities slumped 99.95% in 2024, then surged 323408039.58% in 2025.
- Inventiva's Total Current Liabilities stood at $26.1 million in 2021, then increased by 19.81% to $31.3 million in 2022, then surged by 72.29% to $54.0 million in 2023, then surged by 139.06% to $129.0 million in 2024, then tumbled by 30.18% to $90.1 million in 2025.
- Business Quant data shows IVA's Total Current Liabilities at $90.1 million in Q4 2025, $66.2 billion in Q2 2025, and $129.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | 90.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 90.07 Mn |
| Jun 30, 2025 | 66.17 Mn |
| Dec 31, 2024 | 129.01 Mn |
| Jun 30, 2024 | 20,460.86 |
| Dec 31, 2023 | 53.97 Mn |
| Jun 30, 2023 | 41.16 Mn |
| Dec 31, 2022 | 31.32 Mn |
| Jun 30, 2022 | 25.66 Mn |
| Dec 31, 2021 | 26.14 Mn |
| Jun 30, 2021 | 17.91 Mn |
| Mar 31, 2021 | 19.38 Mn |
| Dec 31, 2020 | 16.58 Mn |
| Jun 30, 2020 | 27.76 Mn |
| Dec 31, 2019 | 15.35 Mn |
| Dec 31, 2018 | 17.21 Mn |